AWARENESS, KNOWLEDGE AND ATTITUDE TOWARDS PHARMACOVIGILANCE AMONG MEDICAL GRADUATES IN A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA.

Authors

  • Arul Amutha Elizabeth L Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.
  • Arvinth A Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.
  • Susshimtha R Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.
  • Sowmiya P Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i6.18129

Keywords:

Questionnaire, Pharmacovigilance, awareness

Abstract

Objectives: As an ever growing scale people are using newer and more effective drugs for various medical conditions. Adverse drug reactions (ADRs) are preventable if the health-care professional pays close attention to the details of the adverse effects, following a drug administration. Awareness about ADRs can decrease the irrational use of drugs. Hence, there is an urgent need to create awareness among the prescribers about the ADR monitoring. Hence, this study is undertaken to assess the awareness, knowledge, and attitude toward Pharmacovigilance among the future health-care professionals.

Methods: Questionnaire-based study was conducted in a tertiary health-care hospital after getting approval from the Institutional Ethical Committee. The questionnaire was developed to assess the knowledge, awareness, and practice of Pharmacovigilance activity. The questions were distributed to the final year students, interns, and postgraduate's students and allowed to write down the answers independently. Each correct answer was given a score of ‘1,' whereas the incorrect/incomplete was given a score of 0.â€

Results and Conclusion: The study reported that awareness (UGs - 53.3%, interns - 54.9%, PGs - 30.75) was adequate among undergraduates and interns, in the knowledge part (UGs-65.5%, interns - 35.4%, PGs - 9.2%), undergraduates excel far than the interns and PGs. However, in the application of Pharmacovigilance (UG - 22.2%, interns - 59.8%, PGs - 63.1%) postgraduates and interns fair better than the undergraduates. Hence, there is need to increase the awareness and also increase the ADR reporting practice among medical graduates.

Downloads

Download data is not yet available.

Author Biographies

Arul Amutha Elizabeth L, Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.

PROFESSOR OF PHARMACOLOGY,

SREE BALAJI MEDICAL COLLEGE,

CHENNAI-44

Arvinth A, Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.

Final year postgraduate, Department of Pharmacology,

Sree Balaji Medical College

Susshimtha R, Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.

Final year postgraduate, Department of Pharmacology,

Sree Balaji Medical College

Sowmiya P, Department of Pharmacology, Sree Balaji Medical College, Chennai, Tamil Nadu, India.

Final year postgraduate, Department of Pharmacology,

Sree Balaji Medical College

References

Gupta SK. Post marketing surveillance. Text Book of Pharmacovigilance. 1st ed. Jaypee Brothers Medical Publishers (P) Ltd.; 2011. p. 75.

Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006;54(3):226-33.

Beijer HJ, de Blaey CJ. Hospitalizations caused by adverse drug

reactions (ADR): A meta-analysis of observational studies. Pharm World Sci 2002;24(2):46-54.

The World Health Organization. Safety of Medicines: A Guide for Detecting and Reporting Adverse Drug Reactions, WHO/EDM/QSM/2002.2. Geneva: World Health Organization; 2002.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol 2007;39:123.

Ministry of Health and Family Welfare. The National Pharmacovigilance Protocol. New Delhi: Ministry of Health and Family Welfare, Government of India; 2004.

Lokesh K. Pharmacovigilance/reporting adverse drug reactions: An approach to enhance health surveillance and extending market share by minimizing the chances of drug withdrawals. Int J Pharm Pharm Sci 2015;7(9):1-7.

Amit D, Rataboli PV. The adverse drug reaction (ADR) notification drop box: An easy way to report ADRs. Br J Clin Pharmacol 2008;66(5):723-4.

Ravi SP, Subish P, Mishra P, Dubey AK. Teaching pharmacovigilance to medical students and doctors. Indian J Pharmacol 2006;38(5):316-9.

Palaian S, Ibrahim MI, Mishra P. Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract Internet 2011;9(4):2.

Karelia BN, Piparava KG. Knowledge, attitude and practice of pharmacovigilance among private healthcare professionals of Rajkot city. Int J Basic Clin Pharmacol 2014;3(1):50.

Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital. Int J PharmTech Res 2011;3(2):678-92.

Rishi RK, Patil RK, Bhandari A. Opinion of physician towards adverse drug reaction reporting, results of pilot study. J Community Nutr Health 2012;1(1):25-9.

Ramesh M, Parthasarathi G. Adverse drug reactions reporting: Attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res 2009;2:10-4.

Kathiria JM, Sattigere BM, Desai PM, Patel SP. A study of adverse drug reactions in patients admitted to intensive care unit of a tertiary care teaching rural hospital. Int J Pharm Pharm Sci 2013;5(1):160-3.

Iffat W, Shakeel S, Naseem S, Imam S, Khan M. Attitudinal survey to assess medical and dental students’ belief of ADR reporting in Pakistan. Int J Pharm Pharm Sci 2014;6(5):279-83.

Gupta SK. Setting up a pharmacovigilance center. Text book of Pharmacovigilance. 1st ed. New Delhi: Jaypee Brothers Medical Publishers; 2011. p. 93-103.

Published

01-06-2017

How to Cite

L, A. A. E., A. A, S. R, and S. P. “ KNOWLEDGE AND ATTITUDE TOWARDS PHARMACOVIGILANCE AMONG MEDICAL GRADUATES IN A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 6, June 2017, pp. 164-7, doi:10.22159/ajpcr.2017.v10i6.18129.

Issue

Section

Original Article(s)